0001209191-22-042002.txt : 20220713
0001209191-22-042002.hdr.sgml : 20220713
20220713101323
ACCESSION NUMBER: 0001209191-22-042002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220712
FILED AS OF DATE: 20220713
DATE AS OF CHANGE: 20220713
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lundberg Sven Ante
CENTRAL INDEX KEY: 0001682126
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37773
FILM NUMBER: 221080350
MAIL ADDRESS:
STREET 1: C/O CRISPR THERAPEUTICS AG
STREET 2: 200 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Merus N.V.
CENTRAL INDEX KEY: 0001651311
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: YALELAAN 62
CITY: 3584 CM UTRECHT
STATE: P7
ZIP: 3584 CM
BUSINESS PHONE: 31 030 253 8800
MAIL ADDRESS:
STREET 1: YALELAAN 62
CITY: 3584 CM UTRECHT
STATE: P7
ZIP: 3584 CM
FORMER COMPANY:
FORMER CONFORMED NAME: Merus B.V.
DATE OF NAME CHANGE: 20150819
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-07-12
0
0001651311
Merus N.V.
MRUS
0001682126
Lundberg Sven Ante
C/O MERUS N.V.
YALELAAN 62
UTRECHT
P7
3584 CM
NETHERLANDS
1
1
0
0
President, CEO & PFO
Common Shares
2022-07-12
4
P
0
4340
22.9688
A
19340
D
Sold in pursuant to 10B5-1 plan dated 6/10/22
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.75 to $23.00, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
/s/ Peter Silverman as attorney-in-fact
2022-07-13